인간 융모성 고나도트로핀(hCG) 시장 : 기술별, 치료 영역별, 최종사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2023-2030년)

Human Chorionic Gonadotropin (hCG) Market with COVID-19 Impact Analysis by Technology, Therapeutic Area, End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

US $ 3,250 ￦ 4,692,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 4,650 ￦ 6,713,000

PDF (5 User License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 5,650 ￦ 8,157,000

PDF & Excel (Enterprise User License)

PDF & Excel 보고서를 동일 기업 내 모든 사용자가 사용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

리포트 하이라이트

인간 융모성 고나도트로핀(hCG) 시장 규모는 2022년에 7억 1,087만 달러를 기록했으며, 2023-2030년 CAGR 6.48%로 확대

인간 융모성 성선자극호르몬(hCG) 시장 - 시장 역학

불임과 성기능 저하증의 유병률 증가, 생활습관의 변화, 불임 치료에 대한 인식이 높아지면서 시장 수요를 촉진할 것입니다.

불임과 성선기능저하증의 유병률 증가, 생활습관의 변화, 불임 치료에 대한 지식의 향상 등이 인간 융모성 성선자극호르몬(HCG) 산업의 성장에 기여하고 있습니다. 예를 들어 성선기능저하증은 혈청내 호르몬인 테스토스테론 농도가 낮은 것으로 정의되며, 아침 발기력 저하, 발기부전, 기억력 저하, 성욕 감퇴, 건강 및 체력 저하, 집중력 저하, 우울증 등 다양한 임상적 특징을 보입니다.2021년7월BMC Endocrine Disorders에서 발표한 연구에 따르면 발기부전은 2021년 세계 성인의 72.2%에 영향을 미칠 것이라고 합니다.

인간 융모성 성선자극호르몬(hCG) 시장 - 주요 인사이트

AnalystView Market Insights의 리서치 애널리스트들이 공유한 분석에 따르면 세계 인간 융모성 성선자극호르몬(hCG) 시장은 예측 기간(2023-2030년) 동안 매년 약 6.48%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.

인간 융모성 성선자극호르몬(hCG) 산업은 불임 및 성선기능저하증 유병률 증가, 생활습관 변화, 불임 치료에 대한 인식 증가로 인해 빠른 속도로 성장할 것으로 예상됩니다.

기술 세분화에 기반하면 천연자원 추출은 2022년에 가장 큰 시장 점유율을 차지할 것으로 예상됩니다.

치료 분야별로는 여성 불임 치료가 2022년 주요 기술로 꼽혔습니다.

최종사용자별로는 불임 치료 클리닉이 2022년 주요 기술로 꼽혔습니다.

지역별로는 북미가 2022년 주요 수입원으로 꼽혔습니다.

인간 융모성 성선자극호르몬(hCG) 시장 - 세분화 분석 :

인간 융모성 성선자극호르몬(hCG) 세계 시장은 기술, 치료 영역, 최종사용자 및 지역을 기준으로 세분화됩니다.

시장은 제품 기술에 따라 재조합 기술 및 천연 유래 추출로 구분됩니다. 천연 유래 추출 부문은 세계 시장을 독점하고 있으며, 예측 기간 중에도 그럴 가능성이 높습니다. hCG 분야의 주요 경쟁사들은 천연 유래 성선자극호르몬에 대한 높은 수요를 가지고 있으며, 이는 지난 수년간 시장의 중요한 개척이며, 이 분야가 벌어들이는 매출에 크게 기여하고 있습니다.

시장은 치료 영역에 따라 남성 성선기능저하증, 여성 불임 치료, 저정자증 치료 및 기타로 분류됩니다. 불임은 부부가 임신을 할 수 없거나 여성이 임신을 지속할 수 없는 상태를 말합니다. 인간 융모성 성선자극호르몬(HCG) 호르몬은 임신 중 배아 발달에 중요한 역할을 하기 때문에 불임 치료에서 HCG를 사용하는 것은 남녀 모두에게 인기가 있습니다. 여성 불임의 원인은 다양합니다. 세계보건기구(WHO)에 따르면 자궁 질환, 난관 막힘, 난포 문제, 다낭성 난소 증후군(PCOS), 다양한 내분비계 질환과 같은 난관 이상이 주요 원인으로 꼽힙니다.

인간 융모성 성선자극호르몬(hCG) 시장 - 지역적 인사이트

지역적으로 이 시장은 북미, 라틴아메리카, 유럽, 아시아태평양 및 중동 및 아프리카에 분포되어 있습니다. 이 지역은 비즈니스를 가져 오는 국가별로 더 세분화됩니다. 예측 기간 중 북미는 상당한 시장 성장을 보일 것으로 예상됩니다. 이러한 증가는 이 지역의 잘 구축된 의료 인프라, 유리한 상환 규정, 불임에 대한 부담 증가와 관련이 있습니다.

인간 융모성 생식샘자극호르몬(hCG) 시장 - 경쟁 상황 :

기업은 기업 웹사이트, E-Commerce 웹사이트, 소매업체, 유통업체, 최종 소비자 등 다양한 채널을 통해 제품을 판매합니다. 기업이 도달 범위를 강화하고 시장 점유율을 확대하기 위해 사용하는 주요 방법에는 신제품 출시, 유통망 개척, R&D 비용, M&A 등이 있습니다. 예를 들어 2022년 6월, 인트로듀케이션 퍼실리티는 불임 치료 전문가와 환자에게 독보적인 경험을 제공하는 장기 생체 조직 및 냉동 보존 솔루션인 HavenCryo를 발표하며 생태계를 확장했습니다.

목차

제1장 인간 융모성 고나도트로핀(hCG) 시장 개요

• 조사 범위
• 시장 추정 연수

제2장 주요 요약

• 시장 내역
• 경쟁 인사이트

제3장 인간 융모성 고나도트로핀(hCG)의 주요 시장 동향

• 시장 촉진요인
• 시장 억제요인
• 시장 기회
• 향후 시장 동향

제4장 인간 융모성 고나도트로핀(hCG) 산업 조사

• PEST 분석
• Porter's Five Forces 분석
• 성장 전망 매핑
• 규제 구조 분석

제5장 인간 융모성 고나도트로핀(hCG) 시장 : COVID-19 감염증의 영향 분석

• 신종 코로나바이러스 감염증 이전의 영향 분석
• 신종 코로나바이러스 감염증 이후의 영향 분석

제6장 인간 융모성 고나도트로핀(hCG) 시장 구도

• 인간 융모성 고나도트로핀(hCG) 시장 점유율 분석, 2022년
• 주요 제조업체별 내역 데이터
  • 기존 기업의 분석
  • 신규 기업의 분석

제7장 인간 융모성 고나도트로핀(hCG) 시장 - 기술별

• 개요
  • 부문 점유율 분석(기술별)
  • 재조합
  • 천연 추출물

제8장 인간 융모성 고나도트로핀(hCG) 시장 - 치료 영역별

• 개요
  • 질환 영역별 부문 점유율 분석
  • 남성 성선기능저하증
  • 여성 불임 치료
  • 핍정자증 치료
  • 기타

제9장 인간 융모성 고나도트로핀(hCG) 시장 - 최종사용자별

• 개요
  • 최종사용자별 부문 점유율 분석
  • 연구기관
  • 불임 클리닉
  • 기타

제10장 인간 융모성 고나도트로핀(hCG) 시장 - 지역별

• 서론
• 북미
  • 개요
  • 북미의 주요 제조업체
  • 미국
  • 캐나다
• 유럽
  • 개요
  • 유럽의 주요 제조업체
  • 독일
  • 이탈리아
  • 영국
  • 프랑스
  • 러시아
  • 네덜란드
  • 스웨덴
  • 폴란드
  • 기타
• 아시아태평양(APAC)
  • 개요
  • 아시아태평양의 주요 제조업체
  • 인도
  • 중국
  • 일본
  • 한국
  • 호주
  • 태국
  • 인도네시아
  • 필리핀
  • 기타
• 라틴아메리카
  • 개요
  • 라틴아메리카의 주요 제조업체
  • 브라질
  • 멕시코
  • 아르헨티나
  • 콜롬비아
  • 기타
• 중동 및 아프리카
  • 개요
  • 중동 및 아프리카의 주요 제조업체
  • 사우디아라비아
  • 아랍에미리트
  • 이스라엘
  • 터키
  • 알제리
  • 이집트
  • 기타

제11장 주요 벤더 분석 - 인간 융모성 고나도트로핀(hCG) 산업

• 경쟁 대시보드
• 기업 개요
  • Zydus Cadila
  • Torrent Pharmaceuticals
  • Sun Pharmaceutical Industries Ltd.
  • Sigma-Aldrich(now part of MilliporeSigma)
  • Organon
  • Novartis
  • Merck
  • Mankind Pharma
  • Lupin Pharmaceuticals
  • Liqvor Pharmaceuticals
  • IBSA Pharma
  • Glenmark Pharmaceuticals
  • Ferring Pharmaceuticals
  • Bharat Serums and Vaccines Ltd.
  • Anhui Anke Biotechnology(Anhui Anke Biotechnology Co., Ltd.)

제12장 애널리스트의 전방위 전망

KSA

영문 목차

영문목차

REPORT HIGHLIGHT

Human Chorionic Gonadotropin (hCG) Market size was valued at USD 710.87 Million in 2022, expanding at a CAGR of 6.48% from 2023 to 2030.

Human Chorionic Gonadotropin (hCG) is a hormone generated by the placenta during pregnancy. It aids pregnancy by activating the corpus luteum in the ovaries to generate progesterone, which maintains the uterine lining and helps the growing fetus. hCG is also the hormone discovered in pregnancy tests since its levels grow considerably early in pregnancy. In addition to its role in reproduction, hCG has therapeutic applications, including as in fertility therapies and as a marker for various medical disorders, including several cancer technologies.

Human Chorionic Gonadotropin (hCG) Market- Market Dynamics

Increasing prevalence of infertility and hypogonadism, changing lifestyles, and increased awareness regarding infertility treatment to propel market demand

The rising prevalence of infertility and hypogonadism, changing lifestyles, and improved knowledge about infertility therapy are all contributing to the expansion of the human chorionic gonadotropin (HCG) industry. Hypogonadism, for example, is defined by low serum the hormone testosterone concentration, which is followed by an array of clinical features such as poor morning erections, ED, memory loss, low libido, physical decline in health and power, difficulty concentrating, and depression. According to research published in July 2021 by BMC Endocrine Disorders, erectile dysfunction would affect 72.2% of adults worldwide in 2021.

Human Chorionic Gonadotropin (hCG) Market- Key Insights

As per the analysis shared by our research analyst, the global Human Chorionic Gonadotropin (hCG) market is estimated to grow annually at a CAGR of around 6.48% over the forecast period (2023-2030)

The Human Chorionic Gonadotropin (hCG) industry is projected to grow at a significant rate due to the increasing prevalence of infertility and hypogonadism, changing lifestyles, and increased awareness regarding infertility treatment

Based on Technology segmentation, natural source extraction was predicted to show maximum market share in the year 2022

Based on Therapeutic Area segmentation, Female Infertility Treatment was the leading Technology in 2022

Based on end user segmentation, Fertility Clinics was the leading Technology in 2022

On the basis of region, North America was the leading revenue generator in 2022

Human Chorionic Gonadotropin (hCG) Market- Segmentation Analysis:

The Global Human Chorionic Gonadotropin (hCG) Market is segmented on the basis of Technology, Therapeutic Area, End User, and Region.

The market is divided into categories based on product Technology: Recombinant Technology and Natural Source Extraction. The natural source extraction segment dominated the worldwide market and is likely to continue to do so during the forecast period. The leading competitors in the hCG sector have a high demand for gonadotropins derived from natural sources, which has been an important development in the market over the past few years and has contributed significantly to the income earned by this segment.

The market is divided into categories based on Therapeutic Area: Male Hypogonadism, Female Infertility Treatment, Oligospermia Treatment, and Others. Infertility is described as the couple's inability to become pregnant or the woman's inability to sustain a pregnancy to term. Because the human chorionic gonadotropin (HCG) hormone is important following embryo development during pregnancy, its usage in infertility therapy has gained popularity in both men and women. Female infertility can be caused by a variety of factors. Tubal abnormalities such as a uterine illness, blocked fallopian tube, follicular problems, polycystic ovarian syndrome (PCOS), various and endocrine system disorders are among the leading causes, according to the World Health Organization.

Human Chorionic Gonadotropin (hCG) Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. Over the projection period, North America is expected to experience considerable market growth. The rise can be linked to the region's well-established healthcare infrastructure, advantageous reimbursement regulations, and the rising burden of infertility.

Human Chorionic Gonadotropin (hCG) Market- Competitive Landscape:

Companies sell their products through a variety of channels, including corporate websites, e-commerce websites, retailers, distributors, and end consumers. Some of the primary techniques used by corporations to strengthen their reach and expand their market share include new product launches, distribution network development, R&D spending, and mergers and acquisitions. For instance, in June 2022, Inception Fertility extended its ecosystem with the introduction of HavenCryo, a long-term biological tissue and cryopreservation preservation solution that provides fertility professionals and patients with a one-of-a-kind experience.

Recent Developments:

In June 2022, with the introduction of HavenCryo, a long-term reproductive tissue and cryopreservation storage solution that provides a distinctive experience for fertility practitioners and patients, Inception Fertility extended its ecosystem.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HUMAN CHORIONIC GONADOTROPIN (HCG) MARKET KEY PLAYERS

• Zydus Cadila
• Torrent Pharmaceuticals
• Sun Pharmaceutical Industries Ltd.
• Sigma-Aldrich (now part of MilliporeSigma)
• Organon
• Novartis
• Merck
• Mankind Pharma
• Lupin Pharmaceuticals
• Liqvor Pharmaceuticals
• IBSA Pharma
• Glenmark Pharmaceuticals
• Ferring Pharmaceuticals
• Bharat Serums and Vaccines Ltd.
• Anhui Anke Biotechnology (Anhui Anke Biotechnology Co., Ltd.)

GLOBAL HUMAN CHORIONIC GONADOTROPIN (HCG) MARKET, BY TECHNOLOGY

• Recombinant Technology
• Natural Source Extraction

GLOBAL HUMAN CHORIONIC GONADOTROPIN (HCG) MARKET, BY THERAPEUTIC AREA

• Male Hypogonadism
• Female Infertility Treatment
• Oligospermia Treatment
• Others

GLOBAL HUMAN CHORIONIC GONADOTROPIN (HCG) MARKET, BY END USER

• Research Institutes
• Fertility Clinics
• Others

GLOBAL HUMAN CHORIONIC GONADOTROPIN (HCG) MARKET, BY REGION

• North America
• The U.S.
• Canada
• Europe
• Germany
• France
• Italy
• Spain
• United Kingdom
• Russia
• Netherlands
• Sweden
• Poland
• Rest of Europe
• Asia Pacific
• India
• China
• South Korea
• Japan
• Australia
• Thailand
• Indonesia
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• United Arab Emirates
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. Human Chorionic Gonadotropin (hCG) Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Human Chorionic Gonadotropin (hCG) Market Snippet by Technology
  • 2.1.2. Human Chorionic Gonadotropin (hCG) Market Snippet by Therapeutic Area
  • 2.1.3. Human Chorionic Gonadotropin (hCG) Market Snippet by End User
  • 2.1.4. Human Chorionic Gonadotropin (hCG) Market Snippet by Country
  • 2.1.5. Human Chorionic Gonadotropin (hCG) Market Snippet by Region
• 2.2. Competitive Insights

3. Human Chorionic Gonadotropin (hCG) Key Market Trends

• 3.1. Human Chorionic Gonadotropin (hCG) Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Human Chorionic Gonadotropin (hCG) Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Human Chorionic Gonadotropin (hCG) Market Opportunities
• 3.4. Human Chorionic Gonadotropin (hCG) Market Future Trends

4. Human Chorionic Gonadotropin (hCG) Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Human Chorionic Gonadotropin (hCG) Market: COVID-19 Impact Analysis

• 5.1. Pre-COVID-19 Impact Analysis
• 5.2. Post-COVID-19 Impact Analysis
  • 5.2.1. Top Performing Segments
  • 5.2.2. Marginal Growth Segments
  • 5.2.3. Top Looser Segments
  • 5.2.4. Marginal Loss Segments

6. Human Chorionic Gonadotropin (hCG) Market Landscape

• 6.1. Human Chorionic Gonadotropin (hCG) Market Share Analysis, 2022
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Human Chorionic Gonadotropin (hCG) Market - By Technology

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Technology, 2022 & 2030 (%)
  • 7.1.2. Recombinant Technology
  • 7.1.3. Natural Source Extraction

8. Human Chorionic Gonadotropin (hCG) Market - By Therapeutic Area

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Therapeutic Area, 2022 & 2030 (%)
  • 8.1.2. Male Hypogonadism
  • 8.1.3. Female Infertility Treatment
  • 8.1.4. Oligospermia Treatment
  • 8.1.5. Others

9. Human Chorionic Gonadotropin (hCG) Market - By End User

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By End User, 2022 & 2030 (%)
  • 9.1.2. Research Institutes
  • 9.1.3. Fertility Clinics
  • 9.1.4. Others

10. Human Chorionic Gonadotropin (hCG) Market- By Geography

• 10.1. Introduction
  • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
• 10.2. North America
  • 10.2.1. Overview
  • 10.2.2. Human Chorionic Gonadotropin (hCG) Key Manufacturers in North America
  • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.2.4. North America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 10.2.5. North America Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
  • 10.2.6. North America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.2.7. U.S.
    • 10.2.7.1. Overview
    • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.2.7.3. U.S. Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.2.7.4. U.S. Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.2.8. Canada
    • 10.2.8.1. Overview
    • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.2.8.3. Canada Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.2.8.4. Canada Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 10.2.8.5. Canada Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
• 10.3. Europe
  • 10.3.1. Overview
  • 10.3.2. Human Chorionic Gonadotropin (hCG) Key Manufacturers in Europe
  • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.3.4. Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 10.3.5. Europe Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
  • 10.3.6. Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.3.7. Germany
    • 10.3.7.1. Overview
    • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.7.3. Germany Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.7.4. Germany Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 10.3.7.5. Germany Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.3.8. Italy
    • 10.3.8.1. Overview
    • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.8.3. Italy Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.8.4. Italy Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 10.3.8.5. Italy Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.3.9. United Kingdom
    • 10.3.9.1. Overview
    • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.9.3. United Kingdom Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.9.4. United Kingdom Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.3.10. France
    • 10.3.10.1. Overview
    • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.10.3. France Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.10.4. France Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 10.3.10.5. France Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.3.11. Russia
    • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.11.2. Russia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.11.3. Russia Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 10.3.11.4. Russia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.3.12. Netherlands
    • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.12.2. Netherlands Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.12.3. Netherlands Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.3.13. Sweden
    • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.13.2. Sweden Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.13.3. Sweden Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.3.14. Poland
    • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.14.2. Poland Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.14.3. Poland Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 10.3.14.4. Poland Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.3.15. Rest of Europe
    • 10.3.15.1. Overview
    • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
• 10.4. Asia Pacific (APAC)
  • 10.4.1. Overview
  • 10.4.2. Human Chorionic Gonadotropin (hCG) Key Manufacturers in Asia Pacific
  • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.4.4. Asia Pacific Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 10.4.5. Asia Pacific Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
  • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.4.7. India
    • 10.4.7.1. Overview
    • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.7.3. India Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.7.4. India Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 10.4.7.5. India Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.4.8. China
    • 10.4.8.1. Overview
    • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.8.3. China Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.8.4. China Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 10.4.8.5. China Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.4.9. Japan
    • 10.4.9.1. Overview
    • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.9.3. Japan Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.9.4. Japan Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 10.4.9.5. Japan Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.4.10. South Korea
    • 10.4.10.1. Overview
    • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.10.3. South Korea Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.10.4. South Korea Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.4.11. Australia
    • 10.4.11.1. Overview
    • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.11.3. Australia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.11.4. Australia Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 10.4.11.5. Australia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.4.12. Thailand
    • 10.4.12.1. Overview
    • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.12.3. Thailand Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.12.4. Thailand Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.4.13. Indonesia
    • 10.4.13.1. Overview
    • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.13.3. Indonesia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.13.4. Indonesia Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.4.14. Philippines
    • 10.4.14.1. Overview
    • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.14.3. Philippines Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.14.4. Philippines Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.4.15. Rest of APAC
    • 10.4.15.1. Overview
    • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.15.3. Rest of APAC Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.15.4. Rest of APAC Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
• 10.5. Latin America
  • 10.5.1. Overview
  • 10.5.2. Human Chorionic Gonadotropin (hCG) Key Manufacturers in Latin America
  • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.5.4. Latin America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 10.5.5. Latin America Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
  • 10.5.6. Latin America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.5.7. Brazil
    • 10.5.7.1. Overview
    • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.7.3. Brazil Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.5.7.4. Brazil Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.5.8. Mexico
    • 10.5.8.1. Overview
    • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.8.3. Mexico Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.5.8.4. Mexico Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.5.9. Argentina
    • 10.5.9.1. Overview
    • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.9.3. Argentina Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.5.9.4. Argentina Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.5.10. Colombia
    • 10.5.10.1. Overview
    • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.10.3. Colombia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.5.10.4. Colombia Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.5.11. Rest of LATAM
    • 10.5.11.1. Overview
    • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
• 10.6. Middle East and Africa
  • 10.6.1. Overview
  • 10.6.2. Human Chorionic Gonadotropin (hCG) Key Manufacturers in Middle East and Africa
  • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.6.4. Middle East and Africa Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 10.6.5. Middle East and Africa Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
  • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.6.7. Saudi Arabia
    • 10.6.7.1. Overview
    • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.6.8. United Arab Emirates
    • 10.6.8.1. Overview
    • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.6.9. Israel
    • 10.6.9.1. Overview
    • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.9.3. Israel Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.6.9.4. Israel Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 10.6.9.5. Israel Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.6.10. Turkey
    • 10.6.10.1. Overview
    • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.10.3. Turkey Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.6.10.4. Turkey Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.6.11. Algeria
    • 10.6.11.1. Overview
    • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.11.3. Algeria Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.6.11.4. Algeria Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.6.12. Egypt
    • 10.6.12.1. Overview
    • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.12.3. Egypt Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.6.12.4. Egypt Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.6.13. Rest of MEA
    • 10.6.13.1. Overview
    • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.13.3. Rest of MEA Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.6.13.4. Rest of MEA Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Human Chorionic Gonadotropin (hCG) Industry

• 11.1. Competitive Dashboard
• 11.2. Company Profiles
  • 11.2.1. Zydus Cadila
  • 11.2.2. Torrent Pharmaceuticals
  • 11.2.3. Sun Pharmaceutical Industries Ltd.
  • 11.2.4. Sigma-Aldrich (now part of MilliporeSigma)
  • 11.2.5. Organon
  • 11.2.6. Novartis
  • 11.2.7. Merck
  • 11.2.8. Mankind Pharma
  • 11.2.9. Lupin Pharmaceuticals
  • 11.2.10. Liqvor Pharmaceuticals
  • 11.2.11. IBSA Pharma
  • 11.2.12. Glenmark Pharmaceuticals
  • 11.2.13. Ferring Pharmaceuticals
  • 11.2.14. Bharat Serums and Vaccines Ltd.
  • 11.2.15. Anhui Anke Biotechnology (Anhui Anke Biotechnology Co., Ltd.)

12. 360 Degree Analyst View

13. Appendix

• 13.1. Research Methodology
• 13.2. References
• 13.3. Abbreviations
• 13.4. Disclaimer
• 13.5. Contact Us

관련자료